G
GLP1Cost
Pricing verified May 2026 · Re-checked monthly

Saxenda Cost in 2026 (And Whether It Is Still Worth It)

By Anthony K C Fong·Last reviewed:

Saxenda's list price is $1,349 per month — the same sticker as Wegovy. Realistic cash-pay paths are narrower than for newer GLP-1s: there is no Saxenda equivalent of NovoCare or LillyDirect self-pay. Combined with 8.4% peak weight loss vs 14.9% for Wegovy and 22.5% for Zepbound, most patients pay less and lose more by switching to a newer once-weekly drug. Below is the honest cost picture as of May 2026.

Affiliate disclosure: This page contains affiliate links. We may earn a commission if you click through and complete a qualifying action. Your price does not change. Affiliate revenue does not influence our pricing data or rankings — full disclosure.

Saxenda cost vs. switching to Wegovy or Zepbound

DrugCheapest cash-payPeak weight loss
Saxenda (liraglutide)$3998.4%
Wegovy (semaglutide)$49914.9%
Zepbound (tirzepatide)$34922.5%

Trial efficacy reflects peak weight loss in primary endpoints. See sources for the underlying citations.

Saxenda cash-pay options in detail

List price (WAC): $1349/month. This is the manufacturer wholesale price; you almost never actually pay this if you have any coverage or program eligibility.

Saxenda Savings Card:Novo Nordisk's commercial-insurance copay reduction program. Drops the copay to ~$25–$75/month for eligible patients whose insurance already covers Saxenda. Apply at saxenda.com. Government insurance excluded by federal rules.

Branded telehealth: $399/month for Saxenda through Hims, Ro, Lemonaid, or LifeMD. Includes the prescriber visit and shipment. Branded telehealth volumes for Saxenda are smaller than for Wegovy or Zepbound — confirm availability before subscribing.

Compounded liraglutide: Effectively unavailable. The FDA never placed liraglutide on the drug-shortage list, so 503A pharmacies do not have a regulatory shield to compound it the way they did for semaglutide and tirzepatide in 2023–2024.

Generic liraglutide (Victoza-equivalent):Generic injectable liraglutide launched in 2024 (Teva) for the type 2 diabetes indication. Generic pricing is lower than branded Saxenda but still typically several hundred dollars per month, and the labeled indication is diabetes — off-label use for weight loss is at your physician's discretion.

When Saxenda still makes sense in May 2026

There are real, narrow scenarios where Saxenda is the right answer despite the cost-and-efficacy gap to newer drugs:

  • Your insurance plan covers Saxenda but specifically denies Wegovy and Zepbound, and prior-authorization appeals have failed.
  • You tolerated liraglutide well in a prior trial and had GI intolerance to semaglutide or tirzepatide.
  • You are pregnancy-planning and your physician is comfortable with liraglutide's longer real-world safety record (though all GLP-1s should typically be discontinued before conception).
  • Your prescriber is more familiar with Saxenda titration than newer drugs (rare in 2026 but not unheard-of for older clinicians).

Outside those scenarios, the math favors switching. Run a side-by-side on Wegovy vs Saxenda or Cheapest GLP-1.

If you decide to switch

Discuss the change with your prescriber rather than self-titrating. Liraglutide and semaglutide are different molecules with different titration schedules; the practical approach is usually to discontinue Saxenda and start the new GLP-1 from its lowest dose, not to overlap or convert dose-for-dose.

Resources to help with the next step:

Frequently asked questions

How much does Saxenda cost in 2026?

The list price (Wholesale Acquisition Cost) is $1,349 per 28-day supply — the same as Wegovy. Branded telehealth runs around $399/month. Saxenda does not have a manufacturer self-pay program equivalent to NovoCare for Wegovy. Insurance copay (where covered) is typically $25–$100/month.

Is Saxenda still worth using in 2026?

For most patients starting GLP-1 therapy in May 2026, no. Saxenda's trial efficacy (8.4% peak weight loss in SCALE) is meaningfully lower than Wegovy's 14.9% (STEP-1) and Zepbound's 22.5% (SURMOUNT-1). It is also a daily injection vs once-weekly for the newer drugs. The two scenarios where Saxenda still makes sense: (1) your insurance covers Saxenda but denies Wegovy/Zepbound, or (2) you tolerate liraglutide better than semaglutide or tirzepatide.

Is there a Saxenda Savings Card?

Yes — Novo Nordisk offers a Saxenda Savings Card that reduces copay for patients with commercial insurance. The card typically caps the copay at around $25–$75/month depending on your plan structure. Apply at saxenda.com. Government insurance — Medicare, Medicaid, Tricare, VA — is excluded by federal anti-kickback rules.

How does Saxenda cost compare to Wegovy?

Saxenda and Wegovy share the same list price ($1,349/month WAC). The difference is what you can do to lower it. Wegovy has the NovoCare self-pay program (around $499/month) and active telehealth supply at branded and compounded tiers. Saxenda has the Savings Card and branded telehealth only — no NovoCare-equivalent self-pay floor. Combined with Wegovy's higher trial efficacy, Wegovy is almost always the better value.

How does Saxenda cost compare to Zepbound?

Zepbound has both a lower list price (~$1,059/month) and Eli Lilly's LillyDirect self-pay vials starting around $349/month for the lower doses. Combined with Zepbound's 22.5% peak weight loss vs Saxenda's 8.4%, the cost-per-pound-lost gap is roughly 3-4x in Zepbound's favor at cash-pay prices. The /compare/saxenda-vs-zepbound page runs the math.

Why is Saxenda a daily injection when Wegovy is weekly?

Saxenda uses liraglutide, a first-generation GLP-1 agonist with a half-life of around 13 hours. Wegovy uses semaglutide, which has a half-life of about a week, enabling once-weekly dosing. Once-weekly drugs hit the market several years after Saxenda and have largely replaced daily injections in clinical practice for weight loss. Adherence in the real world is meaningfully better with weekly dosing.

Is there a generic version of Saxenda?

Generic liraglutide injection is approved in the US (Teva launched the first generic in 2024). However, the labeled indication for the generic is type 2 diabetes (Victoza branding), not weight loss. Generic Victoza-equivalent prices are lower than branded Saxenda but still hundreds of dollars per month, and prescribing for off-label weight loss is up to your physician. This is one of the few GLP-1 generic situations actually available in 2026.

Can I use a GoodRx coupon for Saxenda?

GoodRx coupons sometimes shave a meaningful percentage off retail Saxenda pricing because liraglutide is older and has more pharmacy negotiation room than newer molecules. Check GoodRx and SingleCare against your local pharmacy before assuming. That said, the better question is usually whether to switch off Saxenda entirely.

Stay ahead of every GLP-1 development

We'll email you when something actually matters: new FDA approvals (Foundayo, CagriSema, retatrutide), pricing drops at LillyDirect/NovoCare, telehealth deals, clinical trial results, FDA recalls, and insurance policy changes. ~1-2 emails/month. No filler.

No spam. Unsubscribe anytime. We never sell your email. By submitting, you agree to our Privacy Policy.
Medical disclaimer: This calculator provides estimates only based on phase 3 clinical trial data and publicly listed prices. It is not medical advice. Real-world weight loss varies significantly. Consult a licensed healthcare provider before starting any medication.
💸 Find your cheapest GLP-1 →